A glioma classification scheme based on coexpression modules of EGFR and PDGFRA

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 9, 2014, Pages 3538-3543

  Sun, Yingyu ^a   Zhang, Wei ^b   Chen, Dongfeng ^c   Lv, Yuhong ^a   Zheng, Junxiong ^a   Lilljebjörnd, Henrik ^c   Ran, Liang ^a   Bao, Zhaoshi ^b   Soneson, Charlotte ^c   Olov Sjögren, Hans ^c   Salford, Leif G ^c   Ji, Jianguang ^c   Frenc, Pim J ^d   Fioretose, Thoas ^c   Jiang, Tao ^b   Fan, Xiaolong ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c LUND UNIVERSITY   (Sweden)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER PROGNOSIS; CELL MATURATION; COPY NUMBER VARIATION; GENE EXPRESSION; GENOMICS; GLIAL CELL CULTURE; GLIOMA; HUMAN; MOLECULAR DIAGNOSIS; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGE FACTORS; ANIMALS; CHINA; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MICE; NEURAL STEM CELLS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SIGNAL TRANSDUCTION;

EID: 84895814771     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1313814111     Document Type: Article

References (35)

1. Louis DN, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97-109.
2. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79(7):1381-1393.
3. Lee Y, et al. (2008) Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age. BMC Med Genomics 1:52.
4. Phillips HS, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9(3):157-173.
5. Freije WA, et al. (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64(18):6503-6510.
6. Verhaak RG, et al.; Cancer Genome Atlas Research Network (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98-110.
7. Horvath S, et al. (2006) Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci USA 103(46):17402-17407.
8. Liang Y, et al. (2005) Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci USA 102(16): 5814-5819.
9. Murat A, et al. (2008) Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 26(18):3015-3024.
10. Nutt CL, et al. (2003) Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63(7): 1602-1607.
11. Gravendeel LA, et al. (2009) Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res 69(23):9065-9072.
12. Li A, et al. (2009) Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res 69(5):2091-2099.
13. Turcan S, et al. (2012) IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483(7390):479-483.
14. Noushmehr H, et al.; Cancer Genome Atlas Research Network (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17(5):510-522.
15. Nicolay DJ, Doucette JR, Nazarali AJ (2007) Transcriptional control of oligodendrogenesis. Glia 55(13):1287-1299.
16. Pastrana E, Cheng LC, Doetsch F (2009) Simultaneous prospective purification of adult subventricular zone neural stem cells and their progeny. Proc Natl Acad Sci USA 106(15):6387-6392.
17. Huse JT, Holland EC (2010) Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10(5):319-331.
18. Sun L, et al. (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9(4):287-300.
19. Brunet JP, Tamayo P, Golub TR, Mesirov JP (2004) Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci USA 101(12):4164-4169.
20. Madhavan S, et al. (2009) Rembrandt: Helping personalized medicine become a reality through integrative translational research. Mol Cancer Res 7(2):157-167.
21. Kim TM, Huang W, Park R, Park PJ, Johnson MD (2011) A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res 71(9):3387-3399.
22. Idbaih A, et al. (2008) BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int J Cancer 122(8):1778-1786.
23. Labussière M, et al. (2010) All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2. Neurology 74(23):1886-1890.
24. Baysan M, et al. (2012) G-cimp status prediction of glioblastoma samples using mRNA expression data. PLoS ONE 7(11):e47839.
25. Cahoy JD, et al. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J Neurosci 28(1):264-278.
26. Szerlip NJ, et al. (2012) Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc Natl Acad Sci USA 109(8):3041-3046.
27. Snuderl M, et al. (2011) Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 20(6):810-817.
28. Yan H, et al. (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8): 765-773.
29. Dunn GP, et al. (2012) Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev 26(8):756-784.
30. Mermel CH, et al. (2011) GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 12(4):R41.
31. Persson AI, et al. (2010) Non-stem cell origin for oligodendroglioma. Cancer Cell 18(6): 669-682.
32. Bachoo RM, et al. (2002) Epidermal growth factor receptor and Ink4a/Arf: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1(3):269-277.
33. Oldham MC, et al. (2008) Functional organization of the transcriptome in human brain. Nat Neurosci 11(11):1271-1282.
34. Kang P, et al. (2012) Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesis. Neuron 74(1):79-94.
35. Subramanian A, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545-15550.